Insulin aspart, recombinant Subcutaneous and Valbenazine Tosylate
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Valbenazine Tosylate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: valbenazine
Brand name: Ingrezza
Synonyms: Valbenazine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Valcyte
- Insulin aspart, recombinant Subcutaneous-Valcyte (Valganciclovir Oral Solution)
- Insulin aspart, recombinant Subcutaneous-Valcyte (Valganciclovir Tablets)
- Insulin aspart, recombinant Subcutaneous-Valdecoxib
- Insulin aspart, recombinant Subcutaneous-Valerian
- Insulin aspart, recombinant Subcutaneous-Valerian Root
- Valbenazine Tosylate-Insulin degludec
- Valbenazine Tosylate-Insulin Degludec (U-100) Prefilled Pens
- Valbenazine Tosylate-Insulin Degludec (U-100) Vials
- Valbenazine Tosylate-Insulin Degludec (U-200) Prefilled Pens
- Valbenazine Tosylate-Insulin degludec and liraglutide
- Valbenazine Tosylate-Insulin degludec and liraglutide Subcutaneous